Title Effectiveness of psychological, psychoeducational and psychosocial interventions to prevent postpartum depression in adolescent and adult mothers: study protocol for a systematic review and meta-analysis of randomised controlled trials.
Authors MARTÍN GÓMEZ, CARMEN, Moreno-Peral, Patricia, Bellon, Juan A, Conejo Ceron, Sonia, Campos-Paino, Henar, GÓMEZ GÓMEZ, IRENE, RIGABERT SÁNCHEZ-JUNCO, ALINA, BENÍTEZ BAENA, ISABEL, MOTRICO MARTINEZ , EMMA, MOTRICO MARTINEZ , EMMA, RIGABERT SÁNCHEZ-JUNCO, ALINA, MARTÍN GÓMEZ, CARMEN, BENÍTEZ BAENA, ISABEL, GÓMEZ GÓMEZ, IRENE
External publication No
Means BMJ Open
Scope Article
Nature Científica
JCR Quartile 2
SJR Quartile 1
Area International
Publication date 17/05/2020
DOI 10.1136/bmjopen-2019-034424
Abstract INTRODUCTION: The prevalence of postpartum depression (PPD) is 17%, and the incidence is 12% worldwide. Adverse consequences for mothers and babies have been associated with this disease. To assess the effectiveness of psychological, psychoeducational and psychosocial interventions in preventing PPD, a systematic review and meta-analysis (SR/MA) will be conducted. METHODS AND ANALYSIS: A SR/MA will be performed following the indications of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies will be identified through MEDLINE (Ovid and PubMed), PsycINFO, Web of Science, Scopus, CINAHL, Cochrane Central Register of Controlled Trials, OpenGrey, Australian New Zealand Clinical Trial Registry, ClinicalTrials.gov and evidencebasedtherapy.org from inception until 31 January 2020. Bridging searches will be also conducted until the review is completed. The selection criteria will be as follows: (1) subjects will be pregnant females or females who have given birth in the last 12 months and who were non-depressive at baseline; (2) psychological, psychoeducational and psychosocial interventions; (3) comparator will be usual care, attention control, waiting list or no intervention; (4) outcomes will be specific results on PPD; and (5) the design of the studies will be randomised controlled trials. No restrictions regarding the year of publication, the setting of the intervention or the language of publication will be considered. Pooled standardised mean differences and 95% CIs will be calculated. The risk of bias of the studies will be assessed through the Cochrane Collaboration risk of bias tool. Heterogeneity between the studies will be determined by the I2 and Cochran's Q statistics. Sensitivity and subgroup analyses will also be performed. Publication bias will be checked with funnel plots and Egger's test. Heterogeneity will be explored by random-effects meta-regression analysis. ETHICS AND DISSEMINATION: The ethical assessment was not required. The results will be presented at conferences and disseminated through publications. PROSPERO REGISTRATION NUMBER: CRD42018109981.
Universidad Loyola members